CUSIP: G6S41R101
Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
16,362,756
-
Share change
-
-60,130
-
Total reported value
-
$22,201,010
-
Price per share
-
$1.36
-
Number of holders
-
32
-
Value change
-
-$85,746
-
Number of buys
-
9
-
Number of sells
-
11
Quarterly Holders Quick Answers
What is CUSIP G6S41R101?
CUSIP G6S41R101 identifies RVLPQ - OSMOTICA PHARMACEUTICALS PLC - SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2022
-
Previous quarter:
Q1 2022
Recent filing periods for CUSIP G6S41R101:
Institutional Holders of OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ) as of Q2 2022
As of 30 Jun 2022,
OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,362,756 shares.
The largest 10 holders included
Athyrium Capital Management, LP, Rovida Advisors Inc., ArrowMark Colorado Holdings LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Inc., Marietta Wealth Management, LLC, and TITLEIST ASSET MANAGEMENT, LTD..
This page lists
32
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.